Key result
Prior pre-eclampsia is linked to ~1.9 percentage points lower FMD and more Stage B heart failure.
Why the study?
Does a history of pre-eclampsia reduce endothelial function and increase the prevalence of subclinical heart failure in women several years postpartum?
Observational (n=104)
No
Does a history of pre-eclampsia reduce endothelial function and increase the prevalence of subclinical heart failure in women several years postpartum?
Mean Difference: -1.88 (95% CI -3.59–-0.18)
Absolute Event Rate: 6.12% vs 8.22%
p-value: p=<0.05
Women with a history of pre-eclampsia exhibit lasting endothelial dysfunction and structural cardiac changes indicative of Stage B heart failure, highlighting the need for long-term cardiovascular monitoring.
May warrant enhanced postpartum CV surveillance after pre-eclampsia; leaves open optimal screening and intervention strategies.
Objectives Pre‐eclampsia (PE) is associated with both postpartum endothelial dysfunction and asymptomatic structural heart alterations consistent with heart failure Stage B (HF‐B). In this study, we assessed the relationship between endothelial function, measured by flow‐mediated dilation (FMD), and HF‐B in women with a history of PE. Methods This was an observational study in which 67 formerly pre‐eclamptic women (≥ 4 years postpartum) and 37 healthy parous controls were assessed ultrasonographically for cardiac function and geometry, as well as for endothelial function by means of brachial artery FMD. HF‐B was diagnosed as left ventricular hypertrophy (left ventricular mass index (LVMi) > 95 g/m 2 ), concentric remodeling (relative wall thickness > 0.42 and LVMi ≤ 95 g/m 2 ), mild systolic dysfunction (left ventricular ejection fraction > 40% and < 55%) or asymptomatic valvular disease. Cardiovascular and metabolic syndrome variables were compared between women with history of PE and controls, as well as between those in the formerly pre‐eclamptic group who had HF Stage A, HF‐B or no HF. Logistic regression analysis was performed to assess the associations of FMD with PE, metabolic syndrome risk factors and obstetric parameters. Results The prevalence of HF‐B amongst formerly pre‐eclamptic women was three‐fold higher than that observed for controls (25% vs 8%, P < 0.05), while FMD was lower in formerly pre‐eclamptic women compared with controls (6.12% vs 8.22%, P < 0.01); history of PE remained associated independently with lower FMD after adjusting for metabolic syndrome risk factors and obstetric parameters (β, –1.88; 95% CI, −3.59 to −0.18). However, HF‐B did not relate to low FMD in formerly pre‐eclamptic women. Conclusions Years after pregnancy, formerly pre‐ eclamptic women have lower FMD and have HF‐B more often compared with healthy parous controls. Nonetheless, HF‐B was not related to reduced FMD.
No takes yet. Share an insight, caveat, or question.
Breetveld et al. (2017) conducted an observational in History of pre-eclampsia (n=104). History of pre-eclampsia vs. History of uncomplicated pregnancy (healthy parous controls) was evaluated on Endothelial function measured by flow-mediated dilation (FMD) (MD -1.88, 95% CI -3.59 to -0.18, p=<0.05). Years after pregnancy, women with a history of pre-eclampsia had significantly lower flow-mediated dilation (adjusted mean difference -1.88%) and a higher prevalence of asymptomatic Stage B heart failure compared with healthy parous controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: